Press Releases

Date Title and Summary Additional Formats
Toggle Summary Theravance Announces Data on Novel Anesthesia Program
Theravance Announces Data on Novel Anesthesia Program SOUTH SAN FRANCISCO, Calif., November 24, 2003 /PRNewswire/ -- Theravance, Inc., today announced that results from a study with its investigational intravenous pharmacokinetically-responsive sedative hypnotic THRX-918661 were recently presented
View HTML
Toggle Summary Theravance Announces Promising Results From Multiple Research And Clinical Studies With the Investigational Antibiotic TD-6424
Phase 2 Trials Underway For Serious Infections Caused by Gram-Positive Bacteria
View HTML
Toggle Summary Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines
Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines SOUTH SAN FRANCISCO, CA and LONDON, UK Date: January 6, 2003 Theravance, Inc. and GlaxoSmithKline plc (LSE & NYSE: GSK) announced today that they have formed an alliance to develop and commercialize novel
View HTML

Copyright West LLC. Minimum 15 minutes delayed.

Contact

Toll-Free
877-202-1097

Innoviva Investor Relations & Media
Sloane and Company
212-446-9500

For business development inquiries,
please contact investor.relations@inva.com.